Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-04

Clinical Trial Update: Safety and Efficacy of Etravirine in Friedreich Ataxia Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of etravirine in Friedreich ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • etravirine (etravirine)

Snippet

Sponsor: IRCCS Eugenio Medea | Conditions: Friedreich Ataxia | Phase 2 | Status: COMPLETED